MI Visit the ASPET Website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Molecular Interventions 5:42-46, (2005)
© American Society for Pharmacology and Experimental Therapeutics
10.1124/mi5.1.8
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reinscheid, R. K.
Right arrow Articles by Civelli, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reinscheid, R. K.
Right arrow Articles by Civelli, O.
Review

Neuropeptide S: A New Player in the Modulation of Arousal and Anxiety

Rainer K. Reinscheid1, Yan-Ling Xu1 and Olivier Civelli1,2

1 Department of Pharmacology, 2 Department of Developmental and Cell Biology, University of California Irvine, Irvine, CA 92697-4625


{titleArt_Reinscheid}

Neuropeptide S (NPS) is a newly identified transmitter that modulates arousal and fear responses. NPS activates an orphan G protein–coupled receptor that is expressed throughout the central nervous system, including brain centers that regulate sleep/wakefulness and anxiety. In contrast, the NPS precursor mRNA is found only in a few discrete nuclei in the brainstem as well as in a few scattered cells in the hypothalamus and amygdala. The most prominent expression of NPS precursor is found in a previously uncharacterized cluster of neurons in the pontine area, located between the noradrenergic locus ceruleus and Barrington’s nucleus. Central administration of NPS induces long-lasting arousal and suppresses all stages of sleep. In addition, NPS produces an anxiolytic profile in a variety of behavioral models. The unique pharmacological spectrum of NPS makes it an interesting target for pharmaceutical development. It also enhances our understanding of the neurobiological mechanisms of sleep/wakefulness regulation and the neuronal processing of stress.




This article has been cited by other articles:


Home page
Mol. Interv.Home page
L. S. Stone and D. C. Molliver
In Search of Analgesia: Emerging Poles of GPCRs in Pain
Mol. Interv., October 1, 2009; 9(5): 234 - 251.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Paneda, S. Huitron-Resendiz, L. M. Frago, J. A. Chowen, R. Picetti, L. d. Lecea, and A. J. Roberts
Neuropeptide S Reinstates Cocaine-Seeking Behavior and Increases Locomotor Activity through Corticotropin-Releasing Factor Receptor 1 in Mice
J. Neurosci., April 1, 2009; 29(13): 4155 - 4161.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.